Literature DB >> 22885183

Brd2 is required for cell cycle exit and neuronal differentiation through the E2F1 pathway in mouse neuroepithelial cells.

Mami Tsume1, Chiharu Kimura-Yoshida, Kyoko Mochida, Yukinao Shibukawa, Saori Amazaki, Yoshinao Wada, Ryuji Hiramatsu, Kayo Shimokawa, Isao Matsuo.   

Abstract

To understand genetic programs controlling mammalian central nervous system (CNS) development, we have identified one transgene-inserted mutation, which showed embryonic lethality during neurulation. Determination of the transgene integration site and rescue experiments revealed that the Brd2 gene, whose products specifically bind acetylated histone H4 and can mediate transcription, was the cause of this mutation. Expression studies with specific markers demonstrated that cell cycle progression was accelerated and neuronal differentiation as well as cell cycle exit were impaired in Brd2-deficient neruoepithelial cells. To investigate whether Brd2 regulates neuronal differentiation through a E2F1 transcriptional factor, which directly binds Brd2 and controls genes expression for cell cycle progression and exit, we analyzed Brd2;E2F1 double mutant phenotypes and, consequently found that abnormalities in neuronal differentiation and cell cycle progression due to Brd2-deficiency were restored by removing the E2F1 gene. These findings suggest that Brd2 is required for cell cycle exit and neuronal differentiation of neuroepithelial cells through the E2F1 pathway during mouse CNS development. Crown
Copyright © 2012. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22885183     DOI: 10.1016/j.bbrc.2012.07.149

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.

Authors:  Sarah Picaud; Christopher Wells; Ildiko Felletar; Deborah Brotherton; Sarah Martin; Pavel Savitsky; Beatriz Diez-Dacal; Martin Philpott; Chas Bountra; Hannah Lingard; Oleg Fedorov; Susanne Müller; Paul E Brennan; Stefan Knapp; Panagis Filippakopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-18       Impact factor: 11.205

Review 2.  Targeting bromodomains: epigenetic readers of lysine acetylation.

Authors:  Panagis Filippakopoulos; Stefan Knapp
Journal:  Nat Rev Drug Discov       Date:  2014-04-22       Impact factor: 84.694

3.  Role of BRD4 in hematopoietic differentiation of embryonic stem cells.

Authors:  Ramon M Rodriguez; Beatriz Suarez-Alvarez; Ruben Salvanés; Covadonga Huidobro; Estela G Toraño; Jose L Garcia-Perez; Carlos Lopez-Larrea; Agustin F Fernandez; Clara Bueno; Pablo Menendez; Mario F Fraga
Journal:  Epigenetics       Date:  2014-01-20       Impact factor: 4.528

4.  De Novo Variants in SPOP Cause Two Clinically Distinct Neurodevelopmental Disorders.

Authors:  Maria J Nabais Sá; Geniver El Tekle; Arjan P M de Brouwer; Sarah L Sawyer; Daniela Del Gaudio; Michael J Parker; Farah Kanani; Marie-José H van den Boogaard; Koen van Gassen; Margot I Van Allen; Klaas Wierenga; Gabriela Purcarin; Ellen Roy Elias; Amber Begtrup; Jennifer Keller-Ramey; Tiziano Bernasocchi; Laurens van de Wiel; Christian Gilissen; Hanka Venselaar; Rolph Pfundt; Lisenka E L M Vissers; Jean-Philippe P Theurillat; Bert B A de Vries
Journal:  Am J Hum Genet       Date:  2020-02-27       Impact factor: 11.025

5.  The BRD3 ET domain recognizes a short peptide motif through a mechanism that is conserved across chromatin remodelers and transcriptional regulators.

Authors:  Dorothy C C Wai; Taylor N Szyszka; Amy E Campbell; Cherry Kwong; Lorna E Wilkinson-White; Ana P G Silva; Jason K K Low; Ann H Kwan; Roland Gamsjaeger; James D Chalmers; Wayne M Patrick; Bin Lu; Christopher R Vakoc; Gerd A Blobel; Joel P Mackay
Journal:  J Biol Chem       Date:  2018-03-22       Impact factor: 5.157

Review 6.  Clinical perspectives of BET inhibition in ovarian cancer.

Authors:  Angeliki Andrikopoulou; Michalis Liontos; Konstantinos Koutsoukos; Meletios-Athanasios Dimopoulos; Flora Zagouri
Journal:  Cell Oncol (Dordr)       Date:  2021-01-19       Impact factor: 6.730

7.  Protease Omi facilitates neurite outgrowth in mouse neuroblastoma N2a cells by cleaving transcription factor E2F1.

Authors:  Qi Ma; Qing-song Hu; Ran-jie Xu; Xue-chu Zhen; Guang-hui Wang
Journal:  Acta Pharmacol Sin       Date:  2015-08       Impact factor: 6.150

Review 8.  Targeting bromodomain and extraterminal proteins in breast cancer.

Authors:  Jennifer M Sahni; Ruth A Keri
Journal:  Pharmacol Res       Date:  2017-11-16       Impact factor: 7.658

9.  Identifying gene expression profile of spinal cord injury in rat by bioinformatics strategy.

Authors:  Lingjing Jin; Zhourui Wu; Wei Xu; Xiao Hu; Jin Zhang; Zhigang Xue; Liming Cheng
Journal:  Mol Biol Rep       Date:  2014-03-05       Impact factor: 2.316

10.  Pleiotrophin antagonizes Brd2 during neuronal differentiation.

Authors:  Pablo Garcia-Gutierrez; Francisco Juarez-Vicente; Debra J Wolgemuth; Mario Garcia-Dominguez
Journal:  J Cell Sci       Date:  2014-04-02       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.